Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Verona Pharma Plc (VRNA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | 0 | 0.00 | Sell 100.00% | 0.76 | SEC | ||
| 2025 Q2 | 521,859 | 0.76 | Reduce 70.74% | 1.44 | $94.58 | $49,357,424 | SEC |
| 2025 Q1 | 1,783,498 | 2.04 | Reduce 42.99% | 1.13 | $63.49 | $113,234,288 | SEC |
| 2024 Q4 | 3,128,516 | 2.62 | Reduce 25.79% | 0.61 | $46.44 | $145,288,283 | SEC |
| 2024 Q3 | 4,215,973 | 2.36 | Add 36.32% | 0.63 | $28.77 | $121,293,543 | SEC |
| 2024 Q2 | 3,092,807 | 0.85 | Add 74.16% | 0.36 | $14.46 | $44,721,989 | SEC |
| 2024 Q1 | 1,775,809 | 0.53 | Add 7.20% | 0.04 | $16.09 | $28,572,767 | SEC |
| 2023 Q4 | 1,656,492 | 0.66 | Buy | 0.66 | $19.88 | $32,931,061 | SEC |